News
Pharmaceutical companies in China report importing drugs with tariff exemptions, indicating possible flexibility from Chinese ...
Employing around 760 people at its Dungarvan base, Haleon, formerly GSK, has had a long and deep-rooted connection with ...
2h
Zacks Investment Research on MSNGILD Down on Q1 Earnings and Sales Miss, Oncology Sales DeclineGilead Sciences, Inc. GILD reported lower-than-expected first-quarter 2025 results. Adjusted earnings per share (EPS) of $1.81 missed the Zacks Consensus Estimate by a penny. In the year-ago quarter, ...
4h
Zacks Investment Research on MSNHow to Boost Your Portfolio with Top Medical Stocks Set to Beat EarningsWall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among ...
Onc.AI, a digital health company developing advanced AI-driven clinical management solutions for oncology, today announced that findings from a recent collaboration with global biopharma company GSK ...
The dispensation is the latest sign that the world's two largest economies were prepared to rein in their trade war, ...
A global biopharma is fighting malaria in endemic countries through partnerships that harness R&D, broaden access to ...
Peter Gratton, M.A.P.P., Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, risk management, and public policy. Peter began covering markets at ...
Hanwha, which bought the South Philly yard last year, wants to add waterfront land and may expand into South Jersey.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results